Interleukin 4 inhibits hepatocyte growth factor-induced invasion and migration of colon carcinomas.
Hepatocyte growth factor (HGF) is known to have a number of biological properties including promoting tumor progression of human carcinomas. Metastasis involves a number of events that are attributed to induction by paracrine factors such as HGF. Identification of natural inhibitors of these events would allow better control of tumor progression. Recently we demonstrated that interleukin 4 (IL-4) can regulate proliferation of various human carcinoma cell lines. In the present study, we used established human colon carcinoma cell lines and primary colon carcinoma cell cultures to determine if IL-4 could regulate HGF-induced cell proliferation and other events of tumor progression such as MMP (matrix metalloproteinases)-1, -2, and -9 production, cell migration and cell-matrix invasive activity. All colon carcinoma cell lines expressed HGF and IL-4 receptors. IL-4 significantly inhibited HGF-induced proliferation of one cell line. Cell-matrix invasion was significantly enhanced by HGF (0.1-10 ng/ml); IL-4 (1-10 U/ml) significantly inhibited HGF-induced invasion in a dose-dependent manner. IL-4 also inhibited HGF-induced cell-matrix invasion of metastatic colon carcinoma cells and HGF-induced cell migration. HGF enhanced MMP-1, -2, and -9 production by cell lines. This effect could be inhibited by IL-4. These findings indicate that IL-4 is a potent inhibitor of HGF-induced invasion and metastasis-related functions of human colon carcinoma cells.
John Wayne Cancer Institute, Santa Monica, California 90404, USA.
A
A
Uchiyama
R
R
Essner
F
F
Doi
T
T
Nguyen
K P
KP
Ramming
T
T
Nakamura
D L
DL
Morton
D S
DS
Hoon
D015703:Antigens, CD / Q000378:metabolism; D002455:Cell Division; D002465:Cell Movement; D017364:Collagenases / Q000378:metabolism; D003110:Colonic Neoplasms / Q000473:pathology*; D004587:Electrophoresis, Agar Gel; D006023:Glycoproteins / Q000378:metabolism; D017228:Hepatocyte Growth Factor / Q000037:antagonists & inhibitors*; D006801:Humans; D015847:Interleukin-4 / Q000494:pharmacology*; D020780:Matrix Metalloproteinase 9; D011506:Proteins / Q000378:metabolism; D018123:Receptors, Interleukin / Q000378:metabolism; D019948:Receptors, Interleukin-4; D019716:Tissue Inhibitor of Metalloproteinase-2; D019714:Tissue Inhibitor of Metalloproteinases; D014407:Tumor Cells, Cultured
D015703:Antigens, CD; D006023:Glycoproteins; D011506:Proteins; D018123:Receptors, Interleukin; D019948:Receptors, Interleukin-4; D019714:Tissue Inhibitor of Metalloproteinases; D019716:Tissue Inhibitor of Metalloproteinase-2; D015847:Interleukin-4; D017228:Hepatocyte Growth Factor; D017364:Collagenases; D020780:Matrix Metalloproteinase 9